These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38909931)

  • 1. TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis.
    Ji W; Zhang W; Zhang X; Ke Y
    Cell Signal; 2024 Sep; 121():111268. PubMed ID: 38909931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells.
    Zhou X; Wang Y; Li X; Zhou J; Yang W; Wang X; Jiao S; Zuo W; You Z; Ying W; Wu C; Bao J
    Redox Biol; 2024 Jul; 73():103182. PubMed ID: 38744192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STUB1 promotes the degradation of HSPB1 and induces ferroptosis in lung cancer cells.
    Tieliwaerdi A; Aini A; Amuti M; Aierken Y; Nijiati M; Luo B
    Environ Toxicol; 2024 Aug; 39(8):4156-4170. PubMed ID: 38661247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP24 promotes autophagy-dependent ferroptosis in hepatocellular carcinoma by reducing the K48-linked ubiquitination of Beclin1.
    Cao J; Wu S; Zhao S; Wang L; Wu Y; Song L; Sun C; Liu Y; Liu Z; Zhu R; Liang R; Wang W; Sun Y
    Commun Biol; 2024 Oct; 7(1):1279. PubMed ID: 39379617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis.
    Zhu H; Liu Q; Meng Q; Zhang L; Ju S; Lang J; Zhu D; Chen Y; Aishan N; Ouyang X; Zhang S; Jin L; Xiao L; Wang L; Li L; Ji F
    J Exp Clin Cancer Res; 2024 Aug; 43(1):245. PubMed ID: 39210442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma.
    Wang J; Xiu M; Wang J; Gao Y; Li Y
    J Hematol Oncol; 2024 Sep; 17(1):78. PubMed ID: 39218945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3.
    Wan Y; Cheng J; Gan D; He J; Chen A; Ma J; Li Y; Wang X; Ran J; Chen D; Li J
    Chem Biol Drug Des; 2024 Jun; 103(6):e14565. PubMed ID: 38862254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination.
    Peng L; Wu T; Liu Y; Zhao D; He W; Yuan Y
    Cell Oncol (Dordr); 2024 Jun; 47(3):987-1004. PubMed ID: 38315284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway.
    Ji J; Cheng Z; Zhang J; Wu J; Xu X; Guo C; Feng J
    J Cell Mol Med; 2024 Apr; 28(8):e18335. PubMed ID: 38652216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
    Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
    Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
    [No Abstract]   [Full Text] [Related]  

  • 11. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
    Liu Y; Ouyang L; Mao C; Chen Y; Li T; Liu N; Wang Z; Lai W; Zhou Y; Cao Y; Liu S; Liang Y; Wang M; Liu S; Chen L; Shi Y; Xiao D; Tao Y
    Oncogene; 2022 Jul; 41(27):3570-3583. PubMed ID: 35688944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
    Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C
    Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma.
    Dong FL; Xu ZZ; Wang YQ; Li T; Wang X; Li J
    J Nanobiotechnology; 2024 May; 22(1):298. PubMed ID: 38811968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15-LO.
    Su Y; Zhao D; Jin C; Li Z; Sun S; Xia S; Zhang Y; Zhang Z; Zhang F; Xu X; Shao J; Zhang B; Zheng S
    Oxid Med Cell Longev; 2021; 2021():3456725. PubMed ID: 34925691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
    Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
    Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
    Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
    J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 regulates TFRC ubiquitination and ferroptosis through stabilizing NEDD4L mRNA to impact stroke.
    Su W; Yu X; Wang S; Wang X; Dai Z; Li Y
    Cell Biol Toxicol; 2024 Feb; 40(1):8. PubMed ID: 38302612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.